Jpmorgan Chase & CO Inogen Inc Transaction History

Jpmorgan Chase & CO

$1.14 Trillion
Q2 2024

A detailed history of Jpmorgan Chase & CO transactions in Inogen Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 872,215 shares of INGN stock, worth $8.45 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

872,215

Previous 904,326 3.55%

Holding current value

$8.45 Million

Previous $7.3 Million 2.82%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$6.3 - $8.95 $202,299 - $287,393	-32,111 Reduced 3.55%	872,215 $7.09 Million
Q1 2024 May 10, 2024	BUY	$5.26 - $10.15 $4.46 Million - $8.6 Million	847,043 Added 1478.7%	904,326 $7.3 Million
Q4 2023 Feb 12, 2024	BUY	$4.21 - $6.32 $177,560 - $266,552	42,176 Added 279.18%	57,283 $314,000
Q3 2023 Nov 14, 2023	SELL	$5.14 - $11.28 $269,808 - $592,109	-52,492 Reduced 77.65%	15,107 $78,000
Q2 2023 Aug 11, 2023	BUY	$10.01 - $13.86 $278,638 - $385,806	27,836 Added 70.0%	67,599 $780,000
Q1 2023 May 18, 2023	BUY	$11.88 - $26.0 $342,571 - $749,736	28,836 Added 263.9%	39,763 $496,000
Q1 2023 May 11, 2023	SELL	$11.88 - $26.0 $308,761 - $675,740	-25,990 Reduced 70.4%	10,927 $136,000
Q4 2022 Feb 13, 2023	BUY	$19.14 - $24.55 $45,629 - $58,527	2,384 Added 6.9%	36,917 $728,000
Q3 2022 Nov 14, 2022	BUY	$22.74 - $31.8 $19,215 - $26,871	845 Added 2.51%	34,533 $839,000
Q2 2022 Aug 11, 2022	SELL	$22.88 - $35.28 $30,384 - $46,851	-1,328 Reduced 3.79%	33,688 $815,000
Q1 2022 May 11, 2022	SELL	$28.1 - $35.25 $3.92 Million - $4.91 Million	-139,344 Reduced 79.92%	35,016 $1.14 Million
Q4 2021 Feb 10, 2022	SELL	$29.66 - $44.0 $738,622 - $1.1 Million	-24,903 Reduced 12.5%	174,360 $5.93 Million
Q3 2021 Nov 12, 2021	BUY	$43.09 - $82.26 $8.59 Million - $16.4 Million	199,263 New	199,263 $8.59 Million

Others Institutions Holding INGN

# of Institutions

136

Shares Held

22.1M

Call Options Held

122K

Put Options Held

35.4K

View Full List

About Inogen Inc

Ticker INGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 22,866,500
Market Cap $222M
Description
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...

More about INGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Inogen Inc Transaction History